News and Analysis
Nature Reviews Microbiology 5, 484-487 (July 2007) | doi:10.1038/nrmicro1703
Focus on: Vaccines - Progress & Pitfalls
Vaccine Watch: Tuberculosis vaccines — an update
Peter Andersen1
Top of page
Abstract
The current tuberculosis (TB) vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide, but it does not prevent the establishment of latent TB or reactivation of pulmonary disease in adults. Peter Andersen looks at the progress of the candidates to improve or replace BCG.
Author affiliations
-
Peter Andersen is at the Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark.
Email: pa@ssi.dk
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mycobacterial virulence and specialized secretion: same story, different endingNature Medicine News and Views (01 Mar 2007)
Mycobacterial virulence and specialized secretion: same story, different endingNature Medicine News and Views (01 Mar 2007)
See all 5 matches for News And Views
